<DOC>
	<DOCNO>NCT00053235</DOCNO>
	<brief_summary>This research trial study tissue sample patient ovarian cancer laboratory . Analyzing tissue sample patient laboratory may help doctor learn cancer .</brief_summary>
	<brief_title>Research Study Patients With Advanced Ovarian Epithelial Cancer</brief_title>
	<detailed_description>OBJECTIVES : I . Utilize array comparative genomic hybridization Taqman analyse , quantitative genomic polymerase chain reaction , validate observation gain chromosome 8q predictive short progression-free survival patient primary grade 2 grade 3 advance serous papillary ovarian cancer . II . Utilize analysis determine whether gain chromosome 8q predictive bad overall survival patient . III . Utilize analysis determine whether previously identify chromosomal change ( 3q gain , 7q gain , 16q loss , 17pter-q21 loss ) predict outcome patient association change clinical characteristic . IV . Utilize analysis identify 5 additional chromosomal change association may predict outcome ( progression-free overall survival ) patient . OUTLINE : Genomic DNA isolate optimal cutting temperature ( OCT ) -embedded tissue analyze use comparative genomic hybridization . The chromosomal change identify method compare identify use Taqman method , quantitative genomic polymerase chain reaction analysis . Chromosome 8q specific interest . Other chromosomal change may detect chromosome 3q , 7q , 16q , and/or 17pter-q21 .</detailed_description>
	<mesh_term>Adenocarcinoma</mesh_term>
	<mesh_term>Ovarian Neoplasms</mesh_term>
	<mesh_term>Cystadenocarcinoma</mesh_term>
	<mesh_term>Cystadenocarcinoma , Serous</mesh_term>
	<mesh_term>Adenocarcinoma , Papillary</mesh_term>
	<criteria>Stage III IV , highgrade ( grade 2 3 ) ovarian cancer No borderline lowgrade ( grade 1 ) tumor Tissue predominately serous ovarian cancer No clear cell , endometrioid , mucinous , transitional cell , mixed without predominant serous component Tissue obtain prior optimal suboptimal cytoreductive surgery Must enrol GOG0136 GOG frontline paclitaxel/platinum chemotherapy trial Frozen tissue hematoxylineosin stain section ovary obtain initial surgery Performance status GOG 02</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>